These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 8842057

  • 21. On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles.
    Packhaeuser CB, Kissel T.
    J Control Release; 2007 Nov 06; 123(2):131-40. PubMed ID: 17854938
    [Abstract] [Full Text] [Related]

  • 22. Encapsulation of bovine serum albumin in poly(lactide-co-glycolide) microspheres by the solid-in-oil-in-water technique.
    Castellanos IJ, Carrasquillo KG, López JD, Alvarez M, Griebenow K.
    J Pharm Pharmacol; 2001 Feb 06; 53(2):167-78. PubMed ID: 11273012
    [Abstract] [Full Text] [Related]

  • 23. Preparation and characterization of Japanese encephalitis virus vaccine loaded poly(L-lactide-co-glycolide) microspheres for oral immunization.
    Khang G, Cho JC, Lee JW, Rhee JM, Lee HB.
    Biomed Mater Eng; 1999 Feb 06; 9(1):49-59. PubMed ID: 10436853
    [Abstract] [Full Text] [Related]

  • 24. Preparation and properties of monodispersed rifampicin-loaded poly(lactide-co-glycolide) microspheres.
    Ito F, Makino K.
    Colloids Surf B Biointerfaces; 2004 Nov 25; 39(1-2):17-21. PubMed ID: 15542335
    [Abstract] [Full Text] [Related]

  • 25. Preparation of naltrexone hydrochloride loaded poly (DL-lactide-co-glycolide) microspheres and the effect of polyvinyl alcohol (PVA) as surfactant on the characteristics of the microspheres.
    Suhaida MG, Yahya IB, Darmawati MY.
    Med J Malaysia; 2004 May 25; 59 Suppl B():63-4. PubMed ID: 15468820
    [Abstract] [Full Text] [Related]

  • 26. Morphological and release characterization of nanoparticles formulated with poly (dl-lactide-co-glycolide) (PLGA) and lupeol: In vitro permeability and modulator effect on NF-κB in Caco-2 cell system stimulated with TNF-α.
    Cháirez-Ramírez MH, Sánchez-Burgos JA, Gomes C, Moreno-Jiménez MR, González-Laredo RF, Bernad-Bernad MJ, Medina-Torres L, Ramírez-Mares MV, Gallegos-Infante JA, Rocha-Guzmán NE.
    Food Chem Toxicol; 2015 Nov 25; 85():2-9. PubMed ID: 26260749
    [Abstract] [Full Text] [Related]

  • 27. Poly-lactide-co-glycolide microparticle sizes: a rational factorial design and surface response analysis.
    Namur JA, Cabral-Albuquerque EC, Quintilio W, Santana MH, Politi MJ, de Araujo PS, Lopes AC, da Costa MH.
    J Nanosci Nanotechnol; 2006 Aug 25; 6(8):2403-7. PubMed ID: 17037847
    [Abstract] [Full Text] [Related]

  • 28. Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by a w/o/w solvent evaporation method.
    Leo E, Pecquet S, Rojas J, Couvreur P, Fattal E.
    J Microencapsul; 1998 Aug 25; 15(4):421-30. PubMed ID: 9651864
    [Abstract] [Full Text] [Related]

  • 29. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
    Xu H, Zhong H, Liu M, Xu C, Gao Y.
    Pharmazie; 2011 Sep 25; 66(9):654-61. PubMed ID: 22026119
    [Abstract] [Full Text] [Related]

  • 30. Monitoring microviscosity and microacidity of the albumin microenvironment inside degrading microparticles from poly(lactide-co-glycolide) (PLG) or ABA-triblock polymers containing hydrophobic poly(lactide-co-glycolide) A blocks and hydrophilic poly(ethyleneoxide) B blocks.
    Mäder K, Bittner B, Li Y, Wohlauf W, Kissel T.
    Pharm Res; 1998 May 25; 15(5):787-93. PubMed ID: 9619791
    [Abstract] [Full Text] [Related]

  • 31. Optimization of preparative conditions for polylactide (PLA) microspheres containing ovalbumin.
    Uchida T, Yoshida K, Ninomiya A, Goto S.
    Chem Pharm Bull (Tokyo); 1995 Sep 25; 43(9):1569-73. PubMed ID: 7586084
    [Abstract] [Full Text] [Related]

  • 32. Release of human serum albumin from poly(lactide-co-glycolide) microspheres.
    Hora MS, Rana RK, Nunberg JH, Tice TR, Gilley RM, Hudson ME.
    Pharm Res; 1990 Nov 25; 7(11):1190-4. PubMed ID: 2293220
    [Abstract] [Full Text] [Related]

  • 33. Particle size studies for subcutaneous delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation.
    Uchida T, Goto S, Foster TP.
    J Pharm Pharmacol; 1995 Jul 25; 47(7):556-60. PubMed ID: 8568620
    [Abstract] [Full Text] [Related]

  • 34. Effect of ganciclovir on the hydrolytic degradation of poly(lactide-co-glycolide) microspheres.
    Chen X, Ooi CP, Lim TH.
    J Biomater Appl; 2006 Jan 25; 20(3):287-302. PubMed ID: 16364967
    [Abstract] [Full Text] [Related]

  • 35. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres.
    Janoria KG, Mitra AK.
    Int J Pharm; 2007 Jun 29; 338(1-2):133-41. PubMed ID: 17363204
    [Abstract] [Full Text] [Related]

  • 36. Control of drug loading efficiency and drug release behavior in preparation of hydrophilic-drug-containing monodisperse PLGA microspheres.
    Ito F, Fujimori H, Honnami H, Kawakami H, Kanamura K, Makino K.
    J Mater Sci Mater Med; 2010 May 29; 21(5):1563-71. PubMed ID: 20221788
    [Abstract] [Full Text] [Related]

  • 37. Ivermectin-loaded microparticles for parenteral sustained release: in vitro characterization and effect of some formulation variables.
    Camargo JA, Sapin A, Daloz D, Maincent P.
    J Microencapsul; 2010 May 29; 27(7):609-17. PubMed ID: 20695833
    [Abstract] [Full Text] [Related]

  • 38. Resorbable polymeric microspheres for drug delivery--production and simultaneous surface modification using PEO-PPO surfactants.
    Coombes AG, Scholes PD, Davies MC, Illum L, Davis SS.
    Biomaterials; 1994 Jul 29; 15(9):673-80. PubMed ID: 7948589
    [Abstract] [Full Text] [Related]

  • 39. Stabilization of a model formalinized protein antigen encapsulated in poly(lactide-co-glycolide)-based microspheres.
    Jiang W, Schwendeman SP.
    J Pharm Sci; 2001 Oct 29; 90(10):1558-69. PubMed ID: 11745714
    [Abstract] [Full Text] [Related]

  • 40. Preparation and characterization of negatively charged poly(lactic-co-glycolic acid) microspheres.
    Xu Q, Crossley A, Czernuszka J.
    J Pharm Sci; 2009 Jul 29; 98(7):2377-89. PubMed ID: 19009589
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.